Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Other(3)

Detailed Status

unknown3
Completed3

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown350%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
unknownnot_applicable

Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease

NCT06485128
completednot_applicable

Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children

NCT02991703
unknown

"Escape" Phenomenon of the Antihypertensive Therapy Efficacy

NCT05436730
completednot_applicable

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

NCT02652975
unknown

Coronary Microvascular Dysfunction in Chronic Kidney Disease

NCT04014127
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06485128Not Applicable

Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease

Unknown
NCT02991703Not Applicable

Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children

Completed
NCT05436730

"Escape" Phenomenon of the Antihypertensive Therapy Efficacy

Unknown
NCT02652975Not Applicable

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

Completed
NCT04014127

Coronary Microvascular Dysfunction in Chronic Kidney Disease

Unknown
NCT00588692Not Applicable

Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure

Completed

All 6 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6